Back to search

Article

Appropriate Dose of Ranibizumab for ROP: A Retrospective

2021-07-21

Abstract excerpt

<h4>Objective: </h4> To compare the recurrence rate of retinopathy of prematurity (ROP) after treatment with 0.3 mg vs. 0.25 mg ranibizumab. Subjects: All patients with ROP who underwent intravitreal injection of ranibizumab in Hainan General Hospital between January 2014 and May 2020 were included in this study. <h4>Methods:</h4> 82 cases (146 eyes) who received intravitreal injection of 0.25 mg ranibizumab were...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2f487182-89a9-5b8a-a9b4-49356ea0f3d8
DOI
10.21203/rs.3.rs-677291/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Appropriate Dose of Ranibizumab for ROP: A RetrospectiveDOI 10.21203/rs.3.rs-677291/v1
Select a neighboring publication to make it the new centre.